to assess the effect of arginine vasopressin ( avp ) and 1-deamino-8-d-avp ( ddavp ) on atrial natriuretic peptide ( anp ) release , renal water and electrolyte excretion , and cardiovascular function , avp and ddavp were administered at a dose of 10 ng.kg-1.min-1 iv for 30 min into anesthetized dogs receiving saline infusion at a rate of 1 ml.kg-1.min-1 ( n = 12 ) .
C0011701
atrial natriuretic peptide
C0003779
avp